STEPHAN DIETRICH A (President and CEO) exercised options at NEUBASE THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 9/30/2022ACC: 0001104659-22-104744
DirectorOfficer· President and CEO
Since Jul 2019
0.00
Net shares
Net seller
$825.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
750K acquired · 750K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+750K
Price / share
$0.00
Trade value
$825.00
% of position
1123.2%
9/28/2022
66.78K→816.77K
Total
Net shares
+750K
Net value
$825.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/28/2022 | M · Option Exercise | +750K | $0.00 | $825.00 | 1123.2% | 66.78K | 816.77K |
| Total | +750K | $825.00 | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
750K shares
Shares
−750K
Strike price
0.0011
Held after
2.52M
Exercisable
—
9/28/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock750K shares | 9/28/2022 | M · Option Exercise | −750K | 0.0011 | — | 2.52M |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.27M
Total
1.27M indirect1.27M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.27M | Indirect |
| Total | 1.27M | 1.27M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported